Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bioatla Inc (NQ: BCAB ) 1.730 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Oct 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Bioatla Inc BioAtla and Context Therapeutics Announce Exclusive Worldwide License Agreement to Develop and Commercialize BA3362, a Nectin-4 x CD3 T Cell Engaging Antibody September 23, 2024 From Context Therapeutics Inc. Via GlobeNewswire BioAtla to Participate in the 42nd Annual J.P. Morgan Healthcare Conference December 20, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla Presented Phase 2 Clinical Trial Data at the IASLC 2023 North America Conference on Lung Cancer and Virtual KOL Event December 05, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla to Participate in the JMP Securities Hematology and Oncology Summit November 30, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla to Host Virtual KOL Event to Review IASLC Data on BA3011 in NSCLC November 28, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla Reports Third Quarter 2023 Financial Results and Highlights Recent Progress November 07, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla to Participate in the Jefferies London Healthcare Conference November 06, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla’s Jay M. Short, Ph.D., Selected for The Explorers Club Lowell Thomas Award October 12, 2023 Award recognizes Dr. Short’s contribution to science innovation From BioAtla, Inc. Via GlobeNewswire BioAtla Provides Guidance on Near-Term Milestones and Plans to Announce Third Quarter 2023 Financial Results and Business Update on November 7, 2023 October 10, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla to Participate in the H.C. Wainwright 25th Annual Global Investment Conference September 06, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla to Participate in Upcoming Investor Conferences in August August 03, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla Reports Second Quarter 2023 Financial Results and Highlights Recent Progress August 01, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla to Announce Second Quarter 2023 Financial Results and Provide Business Highlights on August 1, 2023 July 25, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla Added to Membership of U.S. Small-Cap Russell 2000® Index June 26, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla to Participate in the Jefferies Healthcare Conference May 31, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla Reports First Quarter 2023 Financial Results and Highlights Recent Progress May 11, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla to Participate in the JMP Securities Life Sciences Conference May 08, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla to Announce First Quarter 2023 Financial Results and Provide Business Highlights on May 11, 2023 May 04, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Progress March 23, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla to Announce Fourth Quarter and Full-Year 2022 Financial Results and Provide Business Highlights March 16, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla Announces Change in Executive Leadership February 27, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla Announces FDA Clearance of Investigational New Drug Application for BA3182, a CAB-EpCAMxCAB-CD3 Bispecific T-Cell Engager for the Treatment of Advanced Adenocarcinoma February 23, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla Provides Clinical Program Updates and Upcoming 2023 Milestones January 10, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla to Participate in the 41st Annual J.P. Morgan Healthcare Conference December 22, 2022 From BioAtla, Inc. Via GlobeNewswire BioAtla to Participate in the Jefferies London Healthcare Conference November 08, 2022 From BioAtla, Inc. Via GlobeNewswire BioAtla Announces $65 Million Underwritten Offering of its Common Stock November 04, 2022 From BioAtla, Inc. Via GlobeNewswire BioAtla Reports Third Quarter 2022 Financial Results and Highlights Recent Progress November 03, 2022 From BioAtla, Inc. Via GlobeNewswire BioAtla to Announce Third Quarter 2022 Financial Results and Provide Business Highlights on November 3, 2022 October 27, 2022 From BioAtla, Inc. Via GlobeNewswire BioAtla to Announce Second Quarter 2022 Financial Results and Provide Business Highlights on August 9, 2022 August 02, 2022 From BioAtla, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.